Analyst Price Targets — EMR
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 13, 2026 9:50 am | Ken Newman | KeyBanc | $170.00 | $138.88 | TheFly | Emerson price target lowered to $170 from $185 at KeyBanc |
| July 9, 2026 3:36 pm | — | Wolfe Research | $167.00 | $138.90 | TheFly | Emerson price target lowered to $167 from $171 at Wolfe Research |
| June 15, 2026 8:28 pm | Chris Dankert | D.A. Davidson | $145.00 | $146.52 | TheFly | Emerson initiated with a Neutral at DA Davidson |
| June 9, 2026 8:24 pm | Varun Govindaraj | Bernstein | $175.00 | $142.42 | TheFly | Emerson initiated with an Outperform at Bernstein |
| May 6, 2026 12:33 pm | — | RBC Capital | $169.00 | $145.68 | TheFly | Emerson price target raised to $169 from $161 at RBC Capital |
| May 6, 2026 9:36 am | — | Barclays | $144.00 | $138.40 | TheFly | Emerson price target raised to $144 from $140 at Barclays |
| March 26, 2026 8:13 pm | Daniel DiCicco | BMO Capital | $150.00 | $126.31 | TheFly | Emerson initiated with a Market Perform at BMO Capital |
| February 9, 2026 12:19 pm | — | Stephens | $155.00 | $157.38 | TheFly | Emerson price target raised to $155 from $145 at Stephens |
| February 5, 2026 1:21 pm | — | Evercore ISI | $185.00 | $153.02 | TheFly | Emerson price target raised to $185 from $170 at Evercore ISI |
| February 5, 2026 11:56 am | — | KeyBanc | $185.00 | $157.32 | TheFly | Emerson price target raised to $185 from $155 at KeyBanc |
Latest News for EMR
New software solutions integrate planning and scheduling processes to accelerate decision-making Crude Schedule Optimization and Multi-Blend Optimization available in a single, integrated platform Improves refinery margins by automating time-intensive manual workflows Enables refineries to respond more quickly to market volatility and optimize product blending ST. LOUIS, July 16, 2026 /PRNewswire/ -- Global…
ST. LOUIS, July 14, 2026 /PRNewswire/ -- Emerson (NYSE: EMR) will report its third quarter results after market close on Tuesday, August 4, 2026. Emerson senior management will discuss the results during an investor conference call that same day, beginning at 4:30 p.m.
More than 75% of LeqembiÂ-treated patients remained stable and nearly 7% improved over an average of 17 months of treatment in real-world LEAD
LEQEMBIÂ Real-World LEADER Study Presented at AAICÂ 2026 Finds Over 75% of Early Alzheimer's Patients Enrolled in the Study Remained Stable a
Emerson Electric (EMR) reached $135.38 at the closing of the latest trading day, reflecting a -2.52% change compared to its last close.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.